Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACTIN-V for Vaginal Microbiome Restoration in South African Women
NCT05022212Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2021
- Primary completion
- Mar 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus crispatus ctv-05 in bacterial vaginosis (BV), human immunodeficiency virus infection (HIV), sponsored by University of California, San Francisco. Started May 2021; status: completed.
02
Drugs
lactobacillus crispatus ctv-05
03
Conditions
bacterial vaginosis (BV)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05022212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022212.